Quality-of-life evaluations in children and adolescents with Ewing sarcoma treated with pencil-beam-scanning proton therapy.


Journal

Pediatric blood & cancer
ISSN: 1545-5017
Titre abrégé: Pediatr Blood Cancer
Pays: United States
ID NLM: 101186624

Informations de publication

Date de publication:
12 2022
Historique:
revised: 02 08 2022
received: 29 04 2022
accepted: 03 08 2022
pubmed: 3 9 2022
medline: 1 11 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

With improved survival rates for children with cancer, quality-of-life (QoL) issues have increasingly become the focus of attention. We report the QoL of children with Ewing sarcoma (EWS) treated with pencil-beam-scanning proton therapy (PT). A PEDQOL (QoL questionnaire for children 4-18 years) self/proxy questionnaire was used to prospectively assess the QoL of 23 children <18 years with EWS treated with PT. This questionnaire evaluates eight different domains. Children (self-rating) and parents (proxy-rating) filled out the questionnaire at the start of PT (E1), 2 months after treatment (E2), and thereafter once yearly (E≥3). Compared with healthy controls, parents rated the QoL of their children at E1 significantly worse in all but two (cognition and social functioning-family) domains. At E4, significant differences between the two groups only remained in three of eight domains. At E1, children self-rated their QoL significantly worse in the domain Physical functioning (p = .004) and significantly better in the domain Body image (p = .044) compared to healthy controls, whereas no significant differences were observed at E4. For the longitudinal comparison E1 versus E4, according to parents, Emotional functioning, Cognition and Social functioning-peers were slightly decreased 2 years after PT. The children rated Emotional functioning and Body image poorly 2 years after PT. Children with EWS usually recovered seemingly well to normal QoL levels 2 years after the end of PT. They tended to rate their QoL substantially higher than their parents. However, in the longitudinal analysis at 2 years, children rated their Emotional functioning and Body image scores poorly.

Sections du résumé

BACKGROUND
With improved survival rates for children with cancer, quality-of-life (QoL) issues have increasingly become the focus of attention. We report the QoL of children with Ewing sarcoma (EWS) treated with pencil-beam-scanning proton therapy (PT).
METHODS
A PEDQOL (QoL questionnaire for children 4-18 years) self/proxy questionnaire was used to prospectively assess the QoL of 23 children <18 years with EWS treated with PT. This questionnaire evaluates eight different domains. Children (self-rating) and parents (proxy-rating) filled out the questionnaire at the start of PT (E1), 2 months after treatment (E2), and thereafter once yearly (E≥3).
RESULTS
Compared with healthy controls, parents rated the QoL of their children at E1 significantly worse in all but two (cognition and social functioning-family) domains. At E4, significant differences between the two groups only remained in three of eight domains. At E1, children self-rated their QoL significantly worse in the domain Physical functioning (p = .004) and significantly better in the domain Body image (p = .044) compared to healthy controls, whereas no significant differences were observed at E4. For the longitudinal comparison E1 versus E4, according to parents, Emotional functioning, Cognition and Social functioning-peers were slightly decreased 2 years after PT. The children rated Emotional functioning and Body image poorly 2 years after PT.
CONCLUSIONS
Children with EWS usually recovered seemingly well to normal QoL levels 2 years after the end of PT. They tended to rate their QoL substantially higher than their parents. However, in the longitudinal analysis at 2 years, children rated their Emotional functioning and Body image scores poorly.

Identifiants

pubmed: 36052578
doi: 10.1002/pbc.29956
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e29956

Informations de copyright

© 2022 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC.

Références

Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83-103.
Esiashvili N, Goodman M, Marcus RB Jr. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol. 2008;30(6):425-430.
Gaspar N, Hawkins DS, Dirksen U, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol. 2015;33(27):3036-3046.
Ginsberg JP, Goodman P, Leisenring W, et al. Long-term survivors of childhood Ewing sarcoma: report from the childhood cancer survivor study. J Natl Cancer Inst. 2010;102(16):1272-1283.
Novakovic B, Fears TR, Horowitz ME, et al. Late effects of therapy in survivors of Ewing's sarcoma family tumors. J Pediatr Hematol Oncol. 1997;19(3):220-225.
Ranft A, Seidel C, Hoffmann C, et al. Quality of survivorship in a rare disease: clinicofunctional outcome and physical activity in an observational cohort study of 618 long-term survivors of Ewing sarcoma. J Clin Oncol. 2017;35(15):1704-1712.
Stish BJ, Ahmed SK, Rose PS, et al. Patient-reported functional and quality of life outcomes in a large cohort of long-term survivors of Ewing sarcoma. Pediatr Blood Cancer. 2015;62(12):2189-2196.
Stokke J, Sung L, Gupta A, et al. Systematic review and meta-analysis of objective and subjective quality of life among pediatric, adolescent, and young adult bone tumor survivors. Pediatr Blood Cancer. 2015;62(9):1616-1629.
Armstrong GT, Stovall M, Robison LL. Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study. Radiat Res. 2010;174(6):840-850.
Frisch S, Timmermann B. The evolving role of proton beam therapy for sarcomas. Clin Oncol (R Coll Radiol). 2017;29(8):500-506.
Weber DC, Murray FR, Correia D, et al. Pencil beam scanned protons for the treatment of patients with Ewing sarcoma. Pediatr Blood Cancer. 2017;64(12):e26688.
Calaminus G, Weinspach S, Teske C, et al. Quality of survival in children and adolescents after treatment for childhood cancer: the influence of reported late effects on health related quality of life. Klin Padiatr. 2007;219(3):152-157.
Rodrigues KE, Machado ST, Ferreira MA, et al. Health-related quality of life among teenagers during cancer treatment in a developing country: patients' and proxies' reports. Pediatr Hematol Oncol. 2013;30(4):307-316.
Fu L, Talsma D, Beaz F. Health status and health-related quality of life on survivors of cancer in childhood in Central America. Pediatr Blood Cancer. 2005;45:585-586.
Horsman J, Fluchel M, Furlong W, et al. Agreement of the Health Utilities Index scores among survivors of cancer in childhood: their parents and their doctors in Urugay [ISTAHC Conference June 22-25]. Value Health. 2003;6(3):233.
Glaser AW, Furlong W, Walker DA, et al. Applicability of the Health Utilities Index to a population of childhood survivors of central nervous system tumours in the U.K. Eur J Cancer. 1999;35(2):256-261.
Jones JM, McPherson CJ, Zimmermann C, et al. Assessing agreement between terminally ill cancer patients' reports of their quality of life and family caregiver and palliative care physician proxy ratings. J Pain Symptom Manage. 2011;42(3):354-365.
Rensen N, Steur LMH, Schepers SA, et al. Determinants of health-related quality of life proxy rating disagreement between caregivers of children with cancer. Qual Life Res. 2020;29(4):901-912.
Pan R, Egberts MR, Nascimento LC, et al. Health-related quality of life in adolescent survivors of burns: agreement on self-reported and mothers' and fathers' perspectives. Burns. 2015;41(5):1107-1113.
Weitkamp K, Daniels JK, Rosenthal S, et al. Health-related quality of life: cross-informant agreement of father, mother, and self-report for children and adolescents in outpatient psychotherapy treatment. Child Adolesc Ment Health. 2013;18(2):88-94.
Klassen AF, Strohm SJ, Maurice-Stam H, et al. Quality of life questionnaires for children with cancer and childhood cancer survivors: a review of the development of available measures. Support Care Cancer. 2010;18(9):1207-1217.

Auteurs

Damien C Weber (DC)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.
Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Department of Radiation Oncology, University Hospital of Zürich, Zürich, Switzerland.

Jürgen Beer (J)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.
Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Ulrike L Kliebsch (UL)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.

Carmen Teske (C)

Department of Pediatric Hematology and Oncology, Working group Quality of Life, University Hospital Bonn, Bonn, Germany.

Katja Baust (K)

Department of Pediatric Hematology and Oncology, Working group Quality of Life, University Hospital Bonn, Bonn, Germany.

Marc Walser (M)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.
Department of Radiation Oncology, Zentralklinik Bad Berka, Bad Berka, Germany.

Alessia Pica (A)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.

Barbara Bachtiary (B)

Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, Villigen West, Switzerland.

Beate Timmermann (B)

Department of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen (WPE), West German Cancer Centre (WTZ), German Cancer Consortium (DKTK), Essen, Germany.

Gabriele Calaminus (G)

Department of Pediatric Hematology and Oncology, Working group Quality of Life, University Hospital Bonn, Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH